Rat Protein Tyrosine Phosphatase η Suppresses the Neoplastic Phenotype of Retrovirally Transformed Thyroid Cells through the Stabilization of p27Kip1

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Molecular and Cellular Biology

• Publication date

  2000-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/MCB.20.24.9236-9246.2000PMID 11094075PMCID PMC102181
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• Overexpressed cyclin D3 contributes to retaining the growth inhibitor p27 in the cytoplasm of thyroid tumor cells.

  1999cited by this paper
• Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation.

  1998cited by this paper
• PTP‐SL and STEP protein tyrosine phosphatases regulate the activation of the extracellular signal‐regulated kinases ERK1 and ERK2 by association through a kinase interaction motif

  1998cited by this paper
• Protein tyrosine phosphatase-eta expression is upregulated by the PKA-dependent and is downregulated by the PKC-dependent pathways in thyroid cells.

  1998cited by this paper
• Induction of p27Kip1 degradation and anchorage independence by Ras through the MAP kinase signaling pathway

  1997cited by this paper
• Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers

  1997cited by this paper
• Receptor Protein Tyrosine Phosphatase Gamma, Ptpγ, Regulates Hematopoietic Differentiation

  1997cited by this paper
• P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase.

  1997cited by this paper
• Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas

  1997cited by this paper
• Receptor protein tyrosine phosphatase gamma, Ptp gamma, regulates hematopoietic differentiation.

  1997cited by this paper
• Protein tyrosine phosphatases.

  1997cited by this paper
• Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome

  1997cited by this paper
• Thyroid cell transformation inhibits the expression of a novel rat protein tyrosine phosphatase.

  1997cited by this paper
• Germline mutations in PTEN are present in Bannayan-Zonana syndrome

  1997cited by this paper
• Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain.

  1997cited by this paper
• PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer

  1997cited by this paper
• Requirement of p27Kip1 for Restriction Point Control of the Fibroblast Cell Cycle

  1996cited by this paper
• From form to function: signaling by protein tyrosine phosphatases.

  1996cited by this paper
• The protein tyrosine phosphatase DEP-1 is induced during differentiation and inhibits growth of breast cancer cells.

  1996cited by this paper
• Molecular cloning and characterization of Byp, a murine receptor‐type tyrosine phosphatase similar to human DEP‐1

  1996cited by this paper
• Association of Human Protein-tyrosine Phosphatase κ with Members of the Armadillo Family*

  1996cited by this paper
• Formation of p27-CDK complexes during the human mitotic cell cycle.

  1996cited by this paper
• Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27.

  1995cited by this paper
• Inhibitors of mammalian G1 cyclin-dependent kinases.

  1995cited by this paper
• LAR‐PTPase cDNA transfection suppression of tumor growth of neu oncogene‐transformed human breast carcinoma cells

  1995cited by this paper
• Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells

  1995cited by this paper
• Receptor protein tyrosine phosphatase PTPmu associates with cadherins and catenins in vivo

  1995cited by this paper
• The Mos/MAP kinase pathway stabilizes c‐Fos by phosphorylation and augments its transforming activity in NIH 3T3 cells.

  1995cited by this paper
• p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells

  1995cited by this paper
• MAP kinase activation is essential for oncogenic transformation of NIH3T3 cells by Mos.

  1995cited by this paper
• Molecular defects in thyroid carcinomas: role of the RET oncogene in thyroid neoplastic transformation.

  1995cited by this paper
• Expression of DEP-1, a receptor-like protein-tyrosine-phosphatase, is enhanced with increasing cell density.

  1994influential reference
• Receptor protein-tyrosine kinases and their signal transduction pathways.

  1994cited by this paper
• p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.

  1994cited by this paper
• Molecular cloning, characterization, and chromosomal localization of a novel protein-tyrosine phosphatase, HPTP eta.

  1994cited by this paper
• p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.

  1994cited by this paper
• Involvement of p21ras in activation of extracellular signal-regulated kinase 2

  1992cited by this paper
• Pax-8, a paired domain-containing protein, binds to a sequence overlapping the recognition site of a homeodomain and activates transcription from two thyroid-specific promoters

  1992cited by this paper
• Evidence for a Ras-dependent extracellular signal-regulated protein kinase (ERK) cascade.

  1992cited by this paper
• Ras is essential for nerve growth factor- and phorbol ester-induced tyrosine phosphorylation of MAP kinases.

  1992cited by this paper
• Effect of protein tyrosine phosphatase 1B expression on transformation by the human neu oncogene.

  1992cited by this paper
• Receptor protein-tyrosine phosphatase gamma is a candidate tumor suppressor gene at human chromosome region 3p21.

  1991cited by this paper
• Signal transduction by receptors with tyrosine kinase activity.

  1990cited by this paper
• PCR protocols — A guide to methods and applications

  1990cited by this paper
• One- and two-step transformations of rat thyroid epithelial cells by retroviral oncogenes

  1987influential reference
• The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain.

  1986cited by this paper
• Protein-Tryosine Kinases

  1985cited by this paper
• A mos oncogene-containing retrovirus, myeloproliferative sarcoma virus, transforms rat thyroid epithelial cells and irreversibly blocks their differentiation pattern

  1985cited by this paper
• Protein-tyrosine kinases.

  1985cited by this paper
• Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining

  1975cited by this paper
• A new technique for the assay of infectivity of human adenovirus 5 DNA.

  1973cited by this paper
• AGAR SUSPENSION CULTURE FOR THE SELECTIVE ASSAY OF CELLS TRANSFORMED BY POLYOMA VIRUS.

  1964cited by this paper

• The Structure, Function and Regulation of Protein Tyrosine Phosphatase Receptor Type J and Its Role in Diseases

  2022cites this paper
• The effects of CD148 Q276P/R326Q polymorphisms in A431D epidermoid cancer cell proliferation and epidermal growth factor receptor signaling

  2021cites this paper
• Agonistic anti-CD148 monoclonal antibody attenuates diabetic nephropathy in mice.

  2020cites this paper
• Protein tyrosine phosphatases: promising targets in pancreatic ductal adenocarcinoma

  2019cites this paper
• Somatic inactivating PTPRJ mutations and dysregulated pathways identified in canine malignant melanoma by integrated comparative genomic analysis

  2018cites this paper
• The receptor protein tyrosine phosphatase PTPRJ negatively modulates the CD98hc oncoprotein in lung cancer cells

  2018cites this paper
• Design, Synthesis, Biological Activity, and Structural Analysis of Lactam‐Constrained PTPRJ Agonist Peptides

  2018cites this paper
• Tumor suppressive protein phosphatases in human cancer: Emerging targets for therapeutic intervention and tumor stratification.

  2017cites this paper
• Somatic inactivating PTPRJ mutations and dysregulated pathways identified in canine melanoma by integrated comparative genomic analysis

  2017cites this paper
• β-Integrin de-phosphorylation by the Density-Enhanced Phosphatase DEP-1 attenuates EGFR signaling in C. elegans

  2017cites this paper
• Tyrosine Phosphatase PTPRJ/DEP-1 Is an Essential Promoter of Vascular Permeability, Angiogenesis, and Tumor Progression.

  2016cites this paper
• Characterisation of Novel Markers and Effectors of Senescence and their Role in Cancer and Ageing

  2016cites this paper
• A novel splice variant of the protein tyrosine phosphatase PTPRJ that encodes for a soluble protein involved in angiogenesis

  2016cites this paper
• RPTPs and Cancer

  2016cites this paper
• Phosphatases: Their Roles in Cancer and Their Chemical Modulators.

  2016cites this paper
• Determination of the CD148-Interacting Region in Thrombospondin-1

  2016cites this paper
• The protein tyrosine phosphatase DEP-1/PTPRJ promotes breast cancer cell invasion and metastasis

  2015cites this paper
• Blockage of PTPRJ promotes cell growth and resistance to 5-FU through activation of JAK1/STAT3 in the cervical carcinoma cell line C33A.

  2015cites this paper
• In silico analyses reveal common cellular pathways affected by loss of heterozygosity (LOH) events in the lymphomagenesis of Non-Hodgkin’s lymphoma (NHL)

  2014cites this paper
• Phosphorylation of DEP-1/PTPRJ on threonine 1318 regulates Src activation and endothelial cell permeability induced by vascular endothelial growth factor.

  2014cites this paper
• CD148 Tyrosine Phosphatase Promotes Cadherin Cell Adhesion

  2014cites this paper
• Genetic alterations of protein tyrosine phosphatases in human cancers

  2014cites this paper
• Substrate Specificity of R3 Receptor-like Protein-tyrosine Phosphatase Subfamily toward Receptor Protein-tyrosine Kinases*

  2013cites this paper
• The protein tyrosine phosphatase receptor type J is regulated by the pVHL–HIF axis in clear cell renal cell carcinoma

  2013cites this paper
• Tumor suppressor role of the CL2/DRO1/CCDC80 gene in thyroid carcinogenesis.

  2013cites this paper
• Protein tyrosine phosphatase PTPRJ is negatively regulated by microRNA‐328

  2013cites this paper
• of Birmingham Differential Expression of CD148 on leucocyte subsets in inflammatory arthritis

  2013cites this paper
• G 1 checkpoint failure and increased tumor susceptibility in mice lacking the novel p 53 target

  2013cites this paper
• Differential Expression of CD 148 on leucocyte subsets in inflammatory arthritis

  2013cites this paper
• The role of PTPRK and PTPRM in prostate and breast cancer

  2013cites this paper
• Redox-regulation of PTPs; mechanisms and impact on PDGFR signaling

  2013cites this paper
• Discovery of PTPRJ agonist peptides that effectively inhibit in vitro cancer cell proliferation and tube formation.

  2013cites this paper
• Differential expression of CD148 on leukocyte subsets in inflammatory arthritis

  2013cites this paper
• Role of the protein tyrosine phosphatase DEP-1 in Src activation and the mediation of biological cell functions of endothelial and breast cancer cells

  2012influential citation
• Expression and Function of the Protein Tyrosine Phosphatase Receptor J (PTPRJ) in Normal Mammary Epithelial Cells and Breast Tumors

  2012influential citation
• Isolation and functional characterization of peptide agonists of PTPRJ, a tyrosine phosphatase receptor endowed with tumor suppressor activity.

  2012cites this paper
• Tyrosine phosphorylation of DEP-1/CD148 as a mechanism controlling Src kinase activation, endothelial cell permeability, invasion, and capillary formation.

  2012cites this paper
• Receptor type protein tyrosine phosphatases (RPTPs) – roles in signal transduction and human disease

  2012cites this paper
• Thrombospondin-1 acts as a ligand for CD148 tyrosine phosphatase

  2012cites this paper
• PTPRJ (protein tyrosine phosphatase, receptor type, J)

  2012cites this paper
• Investigating the role of PTPRJ in renal cell carcinoma

  2011influential citation
• Association studies in thyroid cancer susceptibility: are we on the right track?

  2011cites this paper
• Regulation of Src Family Kinases Involved in T Cell Receptor Signaling by Protein-tyrosine Phosphatase CD148*

  2011cites this paper
• Association studies in thyroid cancer susceptibility: are we on the right track?

  2011cites this paper
• Functional analysis of the protein tyrosine phosphatase family in mammary epithelial cell models of breast cancer

  2010cites this paper
• Function and regulatory mechanisms of the candidate tumor suppressor receptor protein tyrosine phosphatase gamma (PTPRG) in breast cancer cells.

  2010cites this paper
• Role of PTPRJ genotype in papillary thyroid carcinoma risk.

  2010cites this paper
• Rôle de la protéine tyrosine phosphatase DEP-1 dans la régulation du programmeangiogénique induit par le VEGF

  2010cites this paper
• Protein tyrosine phosphatases expression during development of mouse superior colliculus

  2009cites this paper
• The eighth fibronectin type III domain of protein tyrosine phosphatase receptor J influences the formation of protein complexes and cell localization.

  2009cites this paper
• An unbiased screen identifies DEP-1 tumor suppressor as a phosphatase controlling EGFR endocytosis.

  2009influential citation
• Tumor Suppressor Density-enhanced Phosphatase-1 (DEP-1) Inhibits the RAS Pathway by Direct Dephosphorylation of ERK1/2 Kinases*

  2009cites this paper
• Programme de Biologie Moléculaire

  2009cites this paper
• Impairment of the p 27 kip 1 function enhances thyroid carcinogenesis in TRK-T 1 transgenic mice

  2009cites this paper
• Impairment of the p27kip1 function enhances thyroid carcinogenesis in TRK-T1 transgenic mice.

  2009cites this paper
• Negative RegulatioN of ReceptoR tyRosiNe KiNases by t-cell pRoteiN tyRosiNe phosphatase

  2009cites this paper
• Characterization of an interaction partner of Density Enhanced Phosphatase (DEP-1)

  2009cites this paper
• Density-enhanced Phosphatase 1 Regulates Phosphorylation of Tight Junction Proteins and Enhances Barrier Function of Epithelial Cells*

  2009cites this paper
• CD45, CD148, and Lyp/Pep: critical phosphatases regulating Src family kinase signaling networks in immune cells

  2009cites this paper
• New Role for the Protein Tyrosine Phosphatase DEP-1 in Akt Activation and Endothelial Cell Survival

  2008cites this paper
• The structure of the 5′-end of the protein-tyrosine phosphatase PTPRJ mRNA reveals a novel mechanism for translation attenuation

  2008cites this paper
• The tyrosine phosphatase CD 148 interacts with the p 85 regulatory subunit of phosphoinositide 3-kinase

  2008cites this paper
• Somatostatin receptors 1, 2, and 5 cooperate in the somatostatin inhibition of C6 glioma cell proliferation in vitro via a phosphotyrosine phosphatase-eta-dependent inhibition of extracellularly regulated kinase-1/2.

  2008cites this paper
• The receptor protein-tyrosine phosphatase, Dep1, acts in arterial/venous cell fate decisions in zebrafish development.

  2008cites this paper
• The tyrosine phosphatase CD148 interacts with the p85 regulatory subunit of phosphoinositide 3-kinase.

  2008cites this paper
• UvA-DARE ( Digital Academic Repository ) Colon cancer susceptibility genes in mice and humans

  2008cites this paper
• Study of the physiological function of three putative modifiers of the p53 pathway: Nucleostemin, Ptprv and TCTP

  2008influential citation
• Density-enhanced protein tyrosine phosphatase 1 (DEP-1) regulation of epithelial cell adhesions

  2008influential citation
• Structurally distinct phosphatases CD45 and CD148 both regulate B cell and macrophage immunoreceptor signaling.

  2008cites this paper
• Low-resolution structure and fluorescence anisotropy analysis of protein tyrosine phosphatase eta catalytic domain.

  2007cites this paper
• An intracellular multi-effector complex mediates somatostatin receptor 1 activation of phospho-tyrosine phosphatase eta.

  2007cites this paper
• A Role for CD148 in the control of cell growthand Cell-cell interactions

  2007cites this paper
• Vascular endothelial cell-specific phosphotyrosine phosphatase (VE-PTP) activity is required for blood vessel development.

  2006cites this paper
• Protein tyrosine phosphatases, new targets for cancer therapy.

  2006cites this paper
• Protein-tyrosine phosphatases and cancer

  2006cites this paper
• The receptor-type protein tyrosine phosphatase J antagonizes the biochemical and biological effects of RET-derived oncoproteins.

  2006cites this paper
• Crystallization and preliminary X-ray diffraction analysis of rat protein tyrosine phosphatase η

  2006cites this paper
• Genetic Ablation of Ptprj, a Mouse Cancer Susceptibility Gene, Results in Normal Growth and Development and Does Not Predispose to Spontaneous Tumorigenesis

  2006cites this paper
• Crystallization and preliminary X-ray diffraction analysis of rat protein tyrosine phosphatase eta.

  2006cites this paper
• A monoclonal antibody against CD 148 , a receptor-like tyrosine phosphatase , inhibits endothelial-cell growth and angiogenesis

  2006cites this paper
• Vascular endothelial cell–specific phosphotyrosine phosphatase (VE-PTP) activity is required for blood vessel development

  2006cites this paper
• A monoclonal antibody against CD148, a receptor-like tyrosine phosphatase, inhibits endothelial-cell growth and angiogenesis.

  2006cites this paper
• Identification of gene networks modulated by activin in LbetaT2 cells using DNA microarray analysis.

  2006cites this paper
• DEP-1 protein tyrosine phosphatase inhibits proliferation and migration of colon carcinoma cells and is upregulated by protective nutrients

  2006cites this paper
• Natural compounds as a source of protein tyrosine phosphatase inhibitors: application to the rational design of small-molecule derivatives.

  2006cites this paper
• Role of protein tyrosine phosphatases in cancer.

  2006influential citation
• Histone deacetylase inhibition‐mediated post‐translational elevation of p27KIP1 protein levels is required for G1 arrest in fibroblasts

  2005cites this paper
• The rat tyrosine phosphatase eta increases cell adhesion by activating c-Src through dephosphorylation of its inhibitory phosphotyrosine residue.

  2005cites this paper
• Expression, purification, and characterization of rat protein tyrosine phosphatase η catalytic domain

  2005cites this paper
• cancer: cytoplasmic delocalization induced by the protein kinase Akt"

  2005cites this paper
• G1 checkpoint failure and increased tumor susceptibility in mice lacking the novel p53 target Ptprv

  2005cites this paper
• Expression, purification, and characterization of rat protein tyrosine phosphatase eta catalytic domain.

  2005cites this paper
• The rat tyrosine phosphatase η increases cell adhesion by activating c-Src through dephosphorylation of its inhibitory phosphotyrosine residue

  2005cites this paper
• Allelic association of the human homologue of the mouse modifier Ptprj with breast cancer.

  2005cites this paper
• The C. elegans homolog of the mammalian tumor suppressor Dep-1/Scc1 inhibits EGFR signaling to regulate binary cell fate decisions.

  2005cites this paper
• Structure-based Design of Selective and Potent Inhibitors of Protein-tyrosine Phosphatase β*

  2004cites this paper
• The Tumor Suppressor Gene WWOX at FRA16D Is Involved in Pancreatic Carcinogenesis

  2004cites this paper
• HemopoieticTyrosine Phosphatase CD 148 on Regulated Expression of the Receptor-Like

  2004cites this paper
• Regulated Expression of the Receptor-Like Tyrosine Phosphatase CD148 on Hemopoietic Cells1

  2004cites this paper
• The Phosphotyrosine Phosphatase η Mediates Somatostatin Inhibition of Glioma Proliferation via the Dephosphorylation of ERK1/2

  2004cites this paper